AquaBounty Technologies (AQB) Expected to Announce Earnings on Thursday

AquaBounty Technologies (NASDAQ:AQB) is anticipated to release its results before the market opens on Thursday, March 26th. Analysts expect AquaBounty Technologies to post earnings of ($0.52) per share and revenue of $0.50 million for the quarter.

AquaBounty Technologies Stock Down 5.5%

NASDAQ AQB opened at $0.95 on Thursday. AquaBounty Technologies has a 52 week low of $0.50 and a 52 week high of $2.95. The company has a 50 day moving average price of $0.94 and a 200 day moving average price of $1.15. The firm has a market cap of $3.69 million, a PE ratio of -1.14 and a beta of 1.29.

Institutional Trading of AquaBounty Technologies

An institutional investor recently raised its position in AquaBounty Technologies stock. Renaissance Technologies LLC raised its stake in shares of AquaBounty Technologies, Inc. (NASDAQ:AQB) by 311.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 121,585 shares of the company’s stock after purchasing an additional 92,065 shares during the quarter. Renaissance Technologies LLC owned about 3.14% of AquaBounty Technologies worth $113,000 at the end of the most recent reporting period. Hedge funds and other institutional investors own 8.92% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of AquaBounty Technologies in a report on Monday, December 22nd. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, AquaBounty Technologies currently has an average rating of “Sell”.

AquaBounty Technologies Company Profile

AquaBounty Technologies, Inc is a biotechnology company focused on aquaculture innovation through the development and commercialization of genetically engineered fish. Its flagship product, AquAdvantage Salmon, is an Atlantic salmon strain enhanced with a growth hormone gene that enables faster growth and more efficient feed conversion compared with conventional farmed salmon. By integrating biotechnology into seafood production, AquaBounty aims to address global protein demand while reducing the environmental footprint associated with marine aquaculture.

Founded in 1991, AquaBounty is headquartered in Maynard, Massachusetts, and operates a state-of-the-art, land-based incubation and grow-out facility in Panama.